EMS Limited (EMSLIMITED)
Analysts/Institutional Investor Meet/Con. Call Updates
AI summary
- Q2 FY27 standalone revenue Rs. 160.89 Cr (+30%), EBITDA Rs. 35.82 Cr (+50%), PAT Rs. 22.92 Cr (+50%)
- Order book Rs. 3,152 Cr as of Sep 30, 2026; Rs. 900 Cr new orders pending execution
- Revenue execution expected at ~40% of order book (~Rs. 1,200 Cr) in FY27
- EBITDA margin Q2 at 22.26%, PAT margin 14.25%; target ~25% EBITDA margin by Q4 FY27
- No major CAPEX planned; growth driven by government CAPEX projects
- Collections normalized in UP; some delays in Uttarakhand due to funding portal changes
- Expect 20% CAGR revenue growth over next 2-3 years, recovering from FY26 monsoon impact
- Pledge reduced from Rs. 200 Cr to Rs. 60 Cr; target zero pledge in current financial year
- Management confident of sustaining 30-35% revenue growth and 50% profit growth in Q3 and Q4 FY27
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 EMSLIMITED — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add EMSLIMITED to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on EMS Limited
Important.
The summary above is generated automatically from EMS Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.